Viveve Medical, Inc. (VIVE)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2021 | 25.91 Million USD | 55.82% |
| 2020 | 16.63 Million USD | -38.35% |
| 2019 | 26.97 Million USD | -42.4% |
| 2018 | 46.83 Million USD | 29.81% |
| 2017 | 36.07 Million USD | 147.98% |
| 2016 | 14.54 Million USD | 26.58% |
| 2015 | 11.49 Million USD | 400.17% |
| 2014 | 2.29 Million USD | 47.5% |
| 2013 | 1.55 Million USD | 42.8% |
| 2012 | 1.09 Million USD | -69.26% |
| 2011 | 3.54 Million USD | 7.06% |
| 2010 | 3.31 Million USD | -34.25% |
| 2009 | 5.04 Million USD | -36.28% |
| 2008 | 7.91 Million USD | -29.35% |
| 2007 | 11.2 Million USD | -15.0% |
| 2006 | 13.17 Million USD | 5.69% |
| 2005 | 12.46 Million USD | -6.45% |
| 2004 | 13.32 Million USD | 35.31% |
| 2003 | 9.84 Million USD | -4.64% |
| 2002 | 10.32 Million USD | -16.02% |
| 2001 | 12.29 Million USD | -18.44% |
| 2000 | 15.07 Million USD | -1.57% |
| 1999 | 15.31 Million USD | -6.02% |
| 1998 | 16.3 Million USD | -39.63% |
| 1997 | 27 Million USD | 39.18% |
| 1996 | 19.4 Million USD | 6.01% |
| 1995 | 18.3 Million USD | 27.97% |
| 1994 | 14.3 Million USD | 88.16% |
| 1993 | 7.6 Million USD | 11.76% |
| 1992 | 6.8 Million USD | 28.3% |
| 1991 | 5.3 Million USD | 0.0% |
| 1990 | - USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2022 Q1 | 20.68 Million USD | -20.18% |
| 2022 Q3 | 12.15 Million USD | -21.53% |
| 2022 Q2 | 15.48 Million USD | -25.12% |
| 2021 Q4 | 25.91 Million USD | -14.71% |
| 2021 FY | 25.91 Million USD | 55.82% |
| 2021 Q1 | 37.67 Million USD | 126.52% |
| 2021 Q2 | 34.02 Million USD | -9.67% |
| 2021 Q3 | 30.38 Million USD | -10.71% |
| 2020 Q1 | 21.43 Million USD | -20.55% |
| 2020 Q3 | 19.92 Million USD | -2.95% |
| 2020 Q2 | 20.53 Million USD | -4.2% |
| 2020 FY | 16.63 Million USD | -38.35% |
| 2020 Q4 | 16.63 Million USD | -16.54% |
| 2019 Q1 | 34.85 Million USD | -25.58% |
| 2019 Q4 | 26.97 Million USD | 11.71% |
| 2019 FY | 26.97 Million USD | -42.4% |
| 2019 Q2 | 25.49 Million USD | -26.84% |
| 2019 Q3 | 24.14 Million USD | -5.28% |
| 2018 Q2 | 48.85 Million USD | -13.75% |
| 2018 Q1 | 56.63 Million USD | 56.98% |
| 2018 FY | 46.83 Million USD | 29.81% |
| 2018 Q4 | 46.83 Million USD | 28.53% |
| 2018 Q3 | 36.43 Million USD | -25.41% |
| 2017 Q1 | 39.97 Million USD | 174.76% |
| 2017 FY | 36.07 Million USD | 147.98% |
| 2017 Q4 | 36.07 Million USD | 8.97% |
| 2017 Q3 | 33.1 Million USD | -17.04% |
| 2017 Q2 | 39.91 Million USD | -0.16% |
| 2016 Q1 | 8.66 Million USD | -24.61% |
| 2016 Q2 | 23.06 Million USD | 166.17% |
| 2016 Q3 | 19.1 Million USD | -17.16% |
| 2016 Q4 | 14.54 Million USD | -23.86% |
| 2016 FY | 14.54 Million USD | 26.58% |
| 2015 Q3 | 8.93 Million USD | -16.93% |
| 2015 FY | 11.49 Million USD | 400.17% |
| 2015 Q1 | 1.63 Million USD | -28.89% |
| 2015 Q4 | 11.49 Million USD | 28.68% |
| 2015 Q2 | 10.75 Million USD | 558.08% |
| 2014 Q4 | 2.29 Million USD | -27.03% |
| 2014 Q3 | 3.14 Million USD | 336.8% |
| 2014 Q2 | 721 Thousand USD | 19.37% |
| 2014 Q1 | 604 Thousand USD | -61.23% |
| 2014 FY | 2.29 Million USD | 47.5% |
| 2013 Q1 | 3.56 Million USD | 226.95% |
| 2013 Q3 | 2.48 Million USD | 9.23% |
| 2013 Q2 | 2.27 Million USD | -36.22% |
| 2013 FY | 1.55 Million USD | 42.8% |
| 2013 Q4 | 1.55 Million USD | -37.3% |
| 2012 Q1 | 2.55 Million USD | -28.09% |
| 2012 Q4 | 1.09 Million USD | -39.05% |
| 2012 Q3 | 1.79 Million USD | -2.51% |
| 2012 Q2 | 1.83 Million USD | -28.06% |
| 2012 FY | 1.09 Million USD | -69.26% |
| 2011 FY | 3.54 Million USD | 7.06% |
| 2011 Q4 | 3.54 Million USD | -11.78% |
| 2011 Q3 | 4.02 Million USD | -18.76% |
| 2011 Q2 | 4.95 Million USD | -17.81% |
| 2011 Q1 | 6.02 Million USD | 81.75% |
| 2010 Q4 | 3.31 Million USD | -2.47% |
| 2010 Q1 | 4.23 Million USD | -16.1% |
| 2010 FY | 3.31 Million USD | -34.25% |
| 2010 Q2 | 3.81 Million USD | -9.74% |
| 2010 Q3 | 3.39 Million USD | -10.97% |
| 2009 FY | 5.04 Million USD | -36.28% |
| 2009 Q1 | 6.73 Million USD | -14.85% |
| 2009 Q2 | 6.29 Million USD | -6.53% |
| 2009 Q3 | 5.92 Million USD | -5.94% |
| 2009 Q4 | 5.04 Million USD | -14.89% |
| 2008 Q1 | 10.29 Million USD | -8.06% |
| 2008 Q2 | 8.78 Million USD | -14.69% |
| 2008 Q4 | 7.91 Million USD | -6.93% |
| 2008 FY | 7.91 Million USD | -29.35% |
| 2008 Q3 | 8.5 Million USD | -3.21% |
| 2007 FY | 11.2 Million USD | -15.0% |
| 2007 Q2 | 11.97 Million USD | -4.21% |
| 2007 Q4 | 11.2 Million USD | -6.32% |
| 2007 Q3 | 11.95 Million USD | -0.19% |
| 2007 Q1 | 12.5 Million USD | -5.1% |
| 2006 Q2 | 13.77 Million USD | 1.76% |
| 2006 Q1 | 13.54 Million USD | 8.61% |
| 2006 FY | 13.17 Million USD | 5.69% |
| 2006 Q4 | 13.17 Million USD | -2.55% |
| 2006 Q3 | 13.52 Million USD | -1.87% |
| 2005 Q1 | 13.52 Million USD | 1.49% |
| 2005 Q4 | 12.46 Million USD | -4.0% |
| 2005 Q2 | 13.37 Million USD | -1.12% |
| 2005 FY | 12.46 Million USD | -6.45% |
| 2005 Q3 | 12.98 Million USD | -2.89% |
| 2004 Q3 | 13.38 Million USD | -3.79% |
| 2004 FY | 13.32 Million USD | 35.31% |
| 2004 Q1 | 14.56 Million USD | 47.85% |
| 2004 Q2 | 13.91 Million USD | -4.45% |
| 2004 Q4 | 13.32 Million USD | -0.45% |
| 2003 FY | 9.84 Million USD | -4.64% |
| 2003 Q4 | 9.84 Million USD | -2.04% |
| 2003 Q3 | 10.05 Million USD | -3.64% |
| 2003 Q2 | 10.43 Million USD | 3.42% |
| 2003 Q1 | 10.08 Million USD | -2.31% |
| 2002 Q2 | 10.99 Million USD | -0.04% |
| 2002 Q1 | 10.99 Million USD | -10.56% |
| 2002 FY | 10.32 Million USD | -16.02% |
| 2002 Q4 | 10.32 Million USD | -6.77% |
| 2002 Q3 | 11.07 Million USD | 0.75% |
| 2001 Q3 | 13.59 Million USD | -9.46% |
| 2001 Q2 | 15.01 Million USD | -8.65% |
| 2001 Q1 | 16.43 Million USD | 9.01% |
| 2001 FY | 12.29 Million USD | -18.44% |
| 2001 Q4 | 12.29 Million USD | -9.54% |
| 2000 Q4 | 15.07 Million USD | -13.86% |
| 2000 Q2 | 18.46 Million USD | -0.97% |
| 2000 Q1 | 18.64 Million USD | 21.69% |
| 2000 FY | 15.07 Million USD | -1.57% |
| 2000 Q3 | 17.5 Million USD | -5.18% |
| 1999 Q3 | 15.9 Million USD | 3.92% |
| 1999 FY | 15.31 Million USD | -6.02% |
| 1999 Q1 | 15.8 Million USD | -3.07% |
| 1999 Q2 | 15.3 Million USD | -3.16% |
| 1999 Q4 | 15.31 Million USD | -3.65% |
| 1998 Q2 | 23.7 Million USD | -0.42% |
| 1998 Q4 | 16.3 Million USD | -17.68% |
| 1998 Q3 | 19.8 Million USD | -16.46% |
| 1998 Q1 | 23.8 Million USD | -11.85% |
| 1998 FY | 16.3 Million USD | -39.63% |
| 1997 Q2 | 14.9 Million USD | -10.24% |
| 1997 Q3 | 30.1 Million USD | 102.01% |
| 1997 Q4 | 27 Million USD | -10.3% |
| 1997 FY | 27 Million USD | 39.18% |
| 1997 Q1 | 16.6 Million USD | -14.43% |
| 1996 Q2 | 21.3 Million USD | -4.48% |
| 1996 Q3 | 20.7 Million USD | -2.82% |
| 1996 Q4 | 19.4 Million USD | -6.28% |
| 1996 FY | 19.4 Million USD | 6.01% |
| 1996 Q1 | 22.3 Million USD | 21.86% |
| 1995 FY | 18.3 Million USD | 27.97% |
| 1995 Q4 | 18.3 Million USD | 0.0% |
| 1994 Q2 | 6.8 Million USD | -1.45% |
| 1994 Q3 | 14.2 Million USD | 108.82% |
| 1994 FY | 14.3 Million USD | 88.16% |
| 1994 Q4 | 14.3 Million USD | 0.7% |
| 1994 Q1 | 6.9 Million USD | -9.21% |
| 1993 Q2 | 9 Million USD | 40.63% |
| 1993 Q4 | 7.6 Million USD | -8.43% |
| 1993 Q3 | 8.3 Million USD | -7.78% |
| 1993 FY | 7.6 Million USD | 11.76% |
| 1993 Q1 | 6.4 Million USD | -5.88% |
| 1992 FY | 6.8 Million USD | 28.3% |
| 1992 Q3 | 8 Million USD | 70.21% |
| 1992 Q4 | 6.8 Million USD | -15.0% |
| 1992 Q2 | 4.7 Million USD | -9.62% |
| 1992 Q1 | 5.2 Million USD | -1.89% |
| 1991 FY | 5.3 Million USD | 0.0% |
| 1991 Q4 | 5.3 Million USD | 0.0% |
| 1990 FY | - USD | 0.0% |
| 1990 Q4 | - USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 31.36 Million USD | 17.385% |
| BrainsWay Ltd. | 62.97 Million USD | 58.85% |
| Cerus Corporation | 197.74 Million USD | 86.896% |
| Envoy Medical, Inc. | 7.64 Million USD | -239.175% |
| electroCore, Inc. | 16.38 Million USD | -58.131% |
| Helius Medical Technologies, Inc. | 7.69 Million USD | -236.882% |
| IceCure Medical Ltd | 16.41 Million USD | -57.91% |
| Inogen, Inc. | 326.19 Million USD | 92.056% |
| OrthoPediatrics Corp. | 449.58 Million USD | 94.236% |
| Lucid Diagnostics Inc. | 27.27 Million USD | 4.976% |
| Monogram Orthopaedics, Inc. | 16.57 Million USD | -56.3% |
| MaxCyte, Inc. | 268.27 Million USD | 90.341% |
| NeuroOne Medical Technologies Corporation | 8.09 Million USD | -220.02% |
| Nexalin Technology, Inc. | 3.63 Million USD | -613.48% |
| Orthofix Medical Inc. | 925.31 Million USD | 97.2% |
| PAVmed Inc | 33.11 Million USD | 21.758% |
| Rapid Micro Biosystems, Inc. | 143.45 Million USD | 81.936% |
| RxSight, Inc. | 182.55 Million USD | 85.805% |
| Sight Sciences, Inc. | 166.65 Million USD | 84.451% |
| SI-BONE, Inc. | 230.42 Million USD | 88.754% |
| TELA Bio, Inc. | 78.04 Million USD | 66.799% |
| Treace Medical Concepts, Inc. | 251.9 Million USD | 89.713% |
| Vivos Therapeutics, Inc. | 10.73 Million USD | -141.5% |
| Acutus Medical, Inc. | 53.96 Million USD | 51.977% |
| Talis Biomedical Corporation | 98.34 Million USD | 73.65% |
| Spectral AI, Inc. | 10.69 Million USD | -142.359% |
| Nano-X Imaging Ltd. | 218.64 Million USD | 88.149% |
| CVRx, Inc. | 115.22 Million USD | 77.512% |
| DIH Holding US, Inc. Warrants | 58.66 Million USD | 55.826% |
| PetVivo Holdings, Inc. | 3.11 Million USD | -731.81% |
| Bioventus Inc. | 810.91 Million USD | 96.804% |
| Venus Concept Inc. | 93.65 Million USD | 72.331% |
| TriSalus Life Sciences, Inc. | 25.72 Million USD | -0.731% |
| LivaNova PLC | 2.42 Billion USD | 98.933% |
| 908 Devices Inc. | 202.98 Million USD | 87.234% |
| Alphatec Holdings, Inc. | 805.2 Million USD | 96.782% |
| Nemaura Medical Inc. | 14.56 Million USD | -77.934% |
| NeuroPace, Inc. | 107.65 Million USD | 75.929% |
| LENSAR, Inc. | 69.58 Million USD | 62.761% |
| Apyx Medical Corporation | 79.24 Million USD | 67.298% |
| Cutera, Inc. | 346.29 Million USD | 92.517% |
| STRATA Skin Sciences, Inc. | 42.01 Million USD | 38.326% |
| BioSig Technologies, Inc. | 1.79 Million USD | -1341.212% |
| Anika Therapeutics, Inc. | 270.63 Million USD | 90.425% |
| ClearPoint Neuro, Inc. | 42.66 Million USD | 39.258% |
| Integra LifeSciences Holdings Corporation | 3.78 Billion USD | 99.315% |
| Axonics, Inc. | 719.92 Million USD | 96.401% |
| Outset Medical, Inc. | 313.8 Million USD | 91.742% |
| IRIDEX Corporation | 34.43 Million USD | 24.75% |
| PROCEPT BioRobotics Corporation | 404.71 Million USD | 93.597% |
| IRadimed Corporation | 92.15 Million USD | 71.881% |
| Tivic Health Systems, Inc. | 5.25 Million USD | -393.205% |
| INVO Bioscience, Inc. | 20.88 Million USD | -24.058% |
| Telesis Bio, Inc. | 70.41 Million USD | 63.198% |
| Viemed Healthcare, Inc. | 154.1 Million USD | 83.185% |
| Varex Imaging Corporation | 1.24 Billion USD | 97.926% |
| Quipt Home Medical Corp. | 247.4 Million USD | 89.526% |
| Inspira Technologies Oxy B.H.N. Ltd. | 9.31 Million USD | -178.335% |
| Pulmonx Corporation | 178.95 Million USD | 85.519% |
| Dynatronics Corporation | 25.94 Million USD | 0.106% |
| Modular Medical, Inc. | 13.8 Million USD | -87.68% |
| ReShape Lifesciences Inc. | 10.72 Million USD | -141.568% |
| Semler Scientific, Inc. | 78.06 Million USD | 66.806% |
| InMode Ltd. | 863.28 Million USD | 96.998% |
| Bruker Corporation | 4.24 Billion USD | 99.39% |
| Cytosorbents Corporation | 53.26 Million USD | 51.347% |
| DexCom, Inc. | 6.26 Billion USD | 99.586% |
| Align Technology, Inc. | 6.08 Billion USD | 99.574% |
| ZimVie Inc. | 1.2 Billion USD | 97.85% |
| Movano Inc. | 9.42 Million USD | -175.056% |
| Cytek Biosciences, Inc. | 497.66 Million USD | 94.793% |
| Nexalin Technology, Inc. | 3.63 Million USD | -613.48% |
| DIH Holdings US, Inc. Class A Common Stock | 58.66 Million USD | 55.826% |
| Tandem Diabetes Care, Inc. | 952.65 Million USD | 97.28% |
| Profound Medical Corp. | 43.68 Million USD | 40.684% |
| Insulet Corporation | 2.58 Billion USD | 98.999% |
| enVVeno Medical Corporation | 48.63 Million USD | 46.719% |
| Surmodics, Inc. | 185.73 Million USD | 86.048% |
| iCAD, Inc. | 41.41 Million USD | 37.435% |
| Nuwellis, Inc. | 9.77 Million USD | -165.23% |
| Biotricity, Inc. | 5.94 Million USD | -336.053% |
| iRhythm Technologies, Inc. | 433.14 Million USD | 94.017% |
| Aethlon Medical, Inc. | 8.24 Million USD | -214.25% |
| InspireMD, Inc. | 47.64 Million USD | 45.61% |
| PAVmed Inc. | 33.11 Million USD | 21.758% |
| BIOLASE, Inc. | 35.1 Million USD | 26.176% |
| Beyond Air, Inc. | 56.96 Million USD | 54.507% |
| FONAR Corporation | 214.24 Million USD | 87.905% |
| AxoGen, Inc. | 196.82 Million USD | 86.835% |
| Vivani Medical, Inc. | 45.79 Million USD | 43.418% |
| Tactile Systems Technology, Inc. | 281.43 Million USD | 90.793% |
| Inari Medical, Inc. | 674.23 Million USD | 96.157% |
| UFP Technologies, Inc. | 404.13 Million USD | 93.588% |
| QT Imaging Holdings, Inc. | 23.39 Million USD | -10.746% |
| Heart Test Laboratories, Inc. | 9.5 Million USD | -172.679% |
| Tenon Medical, Inc. | 6.34 Million USD | -308.4% |
| Autonomix Medical, Inc. Common Stock | 9.4 Million USD | -175.465% |
| Co-Diagnostics, Inc. | 103.64 Million USD | 74.999% |
| AdaptHealth Corp. | 4.61 Billion USD | 99.439% |
| Sintx Technologies, Inc. | 15.36 Million USD | -68.65% |
| NanoVibronix, Inc. | 6.67 Million USD | -288.268% |
| Quanterix Corporation | 425.01 Million USD | 93.903% |
| Inspira Technologies Oxy B.H.N. Ltd. | 9.31 Million USD | -178.335% |
| Sensus Healthcare, Inc. | 53.72 Million USD | 51.769% |
| Pacific Biosciences of California, Inc. | 1.74 Billion USD | 98.516% |
| TransMedics Group, Inc. | 706.04 Million USD | 96.33% |
| ReWalk Robotics Ltd. | 63.19 Million USD | 58.993% |
| NeuroMetrix, Inc. | 21.42 Million USD | -20.951% |
| Hyperfine, Inc. | 94.19 Million USD | 72.491% |
| Establishment Labs Holdings Inc. | 268.64 Million USD | 90.354% |
| Biomerica, Inc. | 9.25 Million USD | -180.019% |
| Bone Biologics Corporation | 3.73 Million USD | -593.276% |
| AVITA Medical, Inc. | 144.33 Million USD | 82.047% |
| Bluejay Diagnostics, Inc. | 4.86 Million USD | -432.255% |
| Silk Road Medical, Inc | 265.3 Million USD | 90.233% |